MVD and hepatocellular carcinoma: Although the remaining three genes, PMVK, MVD, and SC5D are currently not targets of existing drugs, they are all related to the main-effect pathway cholesterol biosynthesis and important for tumorigenesis of HCC, which might become novel potential therapeutic targets and worthy of exploration in future studies.